Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ORGO · against 101 other Healthcare companies of similar size
Ranked #72 of 102 · scores higher than 8% of peers
Bars: peers in each 10-point band of the valuation score31 peers with a valuation score of 0–9, including ORGO · Click a bar to see the companies
Mainly because of its earnings yield and EBITDA yield, which are weaker than most Healthcare peers.
| Metric | ORGO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 86 reported | -100.6% | -14.6% | 11% | 30% | |
| EBITDA yieldHigher is better · 110 reported | -3.6% | -2.9% | 48% | 50% | |
| Free cash flow yieldHigher is better · 77 reported | 19.4% | -15.7% | 96% | 20% | |
| Book yieldHigher is better · 91 reported | 138.0% | 75.1% | 68% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 834M HKD (≈$107M) | 99 | 57 | |
| 1 | 1.4B HKD (≈$181M) | 99 | 61 | |
| 1 | 29.0B JPY (≈$197M) | 99 | 56 | |
| 1 | 592M ILS (≈$160M) | 99 | 84 | |
| 72 | 100M CHF (≈$115M) | 8 | ||
| 72 | 68M EUR (≈$75M) | 8 | 34 | |
| 72 | 79M EUR (≈$87M) | 8 | 34 | |
| 72 | 649M SEK (≈$65M) | 8 | 29 | |
| 72 | 107M USD | 8 | 26 | |
| 72 | 124M USD | 8 | 31 | |
| 72 | 170M USD | 8 | 35 | |
| 72 | 139M USD | 8 | 32 | |
| 72 | 172M USD | 8 | 34 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score